Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib

Dermatol Ther. 2022 Sep;35(9):e15724. doi: 10.1111/dth.15724. Epub 2022 Jul 31.

Authors

Dengmei Xia^{1

2}, Yue Xiao¹, Mengmeng Li¹, Wei Li¹

Affiliations

¹ Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
² Department of Dermatology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

PMID: 35855568
DOI: 10.1111/dth.15724

No abstract available

Publication types

Letter

MeSH terms

Amyloidosis, Familial*
Azetidines* / therapeutic use
Dermatitis, Atopic* / complications
Dermatitis, Atopic* / diagnosis
Dermatitis, Atopic* / drug therapy
Humans
Janus Kinase Inhibitors* / therapeutic use
Purines
Pyrazoles
Skin Diseases, Genetic
Sulfonamides

Substances

Azetidines
Janus Kinase Inhibitors
Purines
Pyrazoles
Sulfonamides
baricitinib

Supplementary concepts

Amyloidosis, Primary Cutaneous